![]() |
|
|
Vol. 289, Issue 3, 1398-1403, June 1999
Department of Critical Care Medicine Warren G. Magnusen Clinical
Center (R.W.V., S.M.B., H.L.P., P.J.G., A.F.S., R.L.D.), and the
Biomedical Engineering and Instrumentation Program, Office of Research
Services (A.E., S.B.L.), National Institutes of Health, Bethesda,
Maryland
Ibuprofen has been shown in vitro to modulate production of nitric
oxide (NO), a mediator of sepsis-induced hypotension. We sought to
determine whether ibuprofen alters NO production and, thereby, vascular
tone, in normal and endotoxin-challenged volunteers. Techniques for
detecting NO were validated in 17 subjects infused with sodium
nitroprusside, a NO donor. Then, endotoxin (4 ng/kg) or saline (vehicle
alone) was administered in a single-blinded, crossover design to 12 other subjects randomized to receive either ibuprofen (2400 mg p.o.) or
a placebo. Endotoxin decreased mean arterial pressure (MAP;
P = .002) and increased alveolar NO flow rates
(P = .04) and urinary excretion of nitrite and
nitrate (P = .07). In both endotoxemic and normal
subjects, ibuprofen blunted the small fall in MAP associated with bed
rest (P = .005) and decreased alveolar NO flow
rates (P = .03) and urinary excretion of nitrite
and nitrate (P = .02). However, ibuprofen had no
effect on the decrease in MAP caused by endotoxin, although it blocked NO production to the point of disrupting the normal relationship between increases in exhaled NO flow rate and decreases in MAP (P = .002). These are the first in vivo data to
demonstrate that ibuprofen down-regulates NO in humans. Ibuprofen
impaired the NO response to bed rest, producing a small rise in blood
pressure. Although ibuprofen also interfered with the ability of
endotoxin to induce NO production, it had no effect on the fall in
blood pressure, suggesting that the hemodynamic response to endotoxin is not completely dependent on NO under these conditions.
This article has been cited by other articles:
![]() |
ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate. Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145. [Full Text] [PDF] |
||||
![]() |
J. Pleiner, F. Mittermayer, G. Schaller, C. Marsik, R. J. MacAllister, and M. Wolzt Inflammation-induced vasoconstrictorhyporeactivity is caused by oxidative stress J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1656 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Soop, A. Sollevi, E. Weitzberg, J.O.N. Lundberg, J. Palm, and J. Albert Exhaled NO and plasma cGMP increase after endotoxin infusion in healthy volunteers Eur. Respir. J., April 1, 2003; 21(4): 594 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. PREAS II, A. JUBRAN, R. W. VANDIVIER, D. REDA, P. J. GODIN, S. M. BANKS, M. J. TOBIN, and A. F. SUFFREDINI Effect of Endotoxin on Ventilation and Breath Variability . Role of Cyclooxygenase Pathway Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 620 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF] |
||||
![]() |
J. T. Berg, S. Deem, M. E. Kerr, and E. R. Swenson Hemoglobin and red blood cells alter the response of expired nitric oxide to mechanical forces Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2947 - H2953. [Abstract] [Full Text] [PDF] |
||||